Cargando…
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
BACKGROUND: A previous score predicted death ≤ 2 months following radiotherapy for MSCC. For patients with a high probability of early death, best supportive care was recommended. However, some of these patients may benefit from radiotherapy regarding preservation or improvement of motor function. T...
Autores principales: | Rades, Dirk, Segedin, Barbara, Schild, Steven E., Lomidze, Darejan, Veninga, Theo, Cacicedo, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387005/ https://www.ncbi.nlm.nih.gov/pubmed/35978340 http://dx.doi.org/10.1186/s13014-022-02117-z |
Ejemplares similares
-
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials
por: Rades, Dirk, et al.
Publicado: (2022) -
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials
por: Rades, Dirk, et al.
Publicado: (2021) -
A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses
por: Rades, Dirk, et al.
Publicado: (2015) -
A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression
por: Rades, Dirk, et al.
Publicado: (2018) -
High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study
por: Rades, Dirk, et al.
Publicado: (2017)